[go: up one dir, main page]

AU2002233288A1 - Combined use of Enzyme Inhibitors and Pharmaceutical Preparations thereof for the Treatment and Prophylaxis of Arteriosclerosis, for the Treatment and Prevention of Allergic Reactions of Type I According to the Gell and Coombs Classification, and for the Treatment and Prevention of Dermatological Diseases Associated with FO - Google Patents

Combined use of Enzyme Inhibitors and Pharmaceutical Preparations thereof for the Treatment and Prophylaxis of Arteriosclerosis, for the Treatment and Prevention of Allergic Reactions of Type I According to the Gell and Coombs Classification, and for the Treatment and Prevention of Dermatological Diseases Associated with FO

Info

Publication number
AU2002233288A1
AU2002233288A1 AU2002233288A AU2002233288A AU2002233288A1 AU 2002233288 A1 AU2002233288 A1 AU 2002233288A1 AU 2002233288 A AU2002233288 A AU 2002233288A AU 2002233288 A AU2002233288 A AU 2002233288A AU 2002233288 A1 AU2002233288 A1 AU 2002233288A1
Authority
AU
Australia
Prior art keywords
treatment
prevention
gell
arteriosclerosis
prophylaxis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002233288A
Other versions
AU2002233288B2 (en
AU2002233288B9 (en
Inventor
Siegfried Ansorge
Harald Gollnick
Uwe Lendeckel
Klaus Neubert
Dirk Reinhold
Robert Vetter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMTM GmbH
Original Assignee
IMTM GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2001100052 external-priority patent/DE10100052A1/en
Priority claimed from DE2001102392 external-priority patent/DE10102392A1/en
Priority claimed from DE2001155093 external-priority patent/DE10155093A1/en
Application filed by IMTM GmbH filed Critical IMTM GmbH
Priority claimed from PCT/EP2001/015199 external-priority patent/WO2002053170A2/en
Publication of AU2002233288A1 publication Critical patent/AU2002233288A1/en
Assigned to IMTM GMBH reassignment IMTM GMBH Amend patent request/document other than specification (104) Assignors: INSTITUT FUR MEDIZINTECHNOLOGIE MAGDEBURG GMBH IMTM
Publication of AU2002233288B2 publication Critical patent/AU2002233288B2/en
Application granted granted Critical
Publication of AU2002233288B9 publication Critical patent/AU2002233288B9/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002233288A 2001-01-02 2001-12-21 Combined use of Enzyme Inhibitors and Pharmaceutical Preparations thereof for the Treatment and Prophylaxis of Arteriosclerosis, for the Treatment and Prevention of Allergic Reactions of Type I According to the Gell and Coombs Classification, and for the Treatment and Prevention of Dermatological Diseases Associated with FO Ceased AU2002233288B9 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DE2001100052 DE10100052A1 (en) 2001-01-02 2001-01-02 Inhibiting DNA synthesis in T-lymphocytes, keratinocytes and TH2 cytokine production, comprises combined administration of dipeptidyl peptidase and alanyl-aminopeptidase inhibitors
DE10100052.9 2001-01-02
DE10102392.8 2001-01-19
DE2001102392 DE10102392A1 (en) 2001-01-19 2001-01-19 Inhibiting DNA synthesis in T-lymphocytes, keratinocytes and TH2 cytokine production, comprises combined administration of dipeptidyl peptidase and alanyl-aminopeptidase inhibitors
DE10155093.6 2001-11-09
DE2001155093 DE10155093A1 (en) 2001-11-09 2001-11-09 Inhibiting DNA synthesis in T-lymphocytes, keratinocytes and TH2 cytokine production, comprises combined administration of dipeptidyl peptidase and alanyl-aminopeptidase inhibitors
PCT/EP2001/015199 WO2002053170A2 (en) 2001-01-02 2001-12-21 Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prophylaxis of arteriosclerosis, for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological diseases associated with fo

Publications (3)

Publication Number Publication Date
AU2002233288A1 true AU2002233288A1 (en) 2003-01-23
AU2002233288B2 AU2002233288B2 (en) 2005-10-20
AU2002233288B9 AU2002233288B9 (en) 2007-08-09

Family

ID=27214230

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002233288A Ceased AU2002233288B9 (en) 2001-01-02 2001-12-21 Combined use of Enzyme Inhibitors and Pharmaceutical Preparations thereof for the Treatment and Prophylaxis of Arteriosclerosis, for the Treatment and Prevention of Allergic Reactions of Type I According to the Gell and Coombs Classification, and for the Treatment and Prevention of Dermatological Diseases Associated with FO

Country Status (8)

Country Link
US (2) US7229969B2 (en)
EP (1) EP1349576B1 (en)
JP (1) JP2004520330A (en)
CN (1) CN100579582C (en)
AT (1) ATE534433T1 (en)
AU (1) AU2002233288B9 (en)
CA (2) CA2627862C (en)
WO (1) WO2002053170A2 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10025464A1 (en) * 2000-05-23 2001-12-06 Inst Medizintechnologie Magdeb Combined use of enzyme inhibitors for the therapy of autoimmune diseases, in transplants and tumor diseases, as well as combinations of pharmaceutical preparations comprising enzyme inhibitors
DE10100053A1 (en) * 2001-01-02 2002-08-22 Keyneurotek Ag I G Use of enzyme inhibitors of dipeptidyl peptidase IV and aminopeptidase N and pharmaceutical preparations therefrom for the prevention and / or therapy of ischemia-related acute and chronic neurodegenerative processes and diseases
WO2002053170A2 (en) * 2001-01-02 2002-07-11 Institut Für Medizintechnologie Magdeburg Gmbh (Imtm) Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prophylaxis of arteriosclerosis, for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological diseases associated with fo
US20030119036A1 (en) * 2001-10-31 2003-06-26 Millennium Pharmaceuticals, Inc. Methods of using 48149, a human aminopeptidase family member
DE10211555A1 (en) * 2002-03-15 2003-10-02 Imtm Inst Fuer Medizintechnolo Use of the inhibitors of enzymes with activities of the aminopeptidase N and / or the dipeptidyl peptidase IV and pharmaceutical preparations thereof for the therapy and prevention of dermatological diseases with sebocytic hyperproliferation and changed differentiation states
TW200404796A (en) * 2002-08-19 2004-04-01 Ono Pharmaceutical Co Nitrogen-containing compound
KR20050122220A (en) 2003-03-25 2005-12-28 다케다 샌디에고, 인코포레이티드 Dipeptidyl peptidase inhibitors
EP1625122A1 (en) 2003-05-14 2006-02-15 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
EP1631680A2 (en) * 2003-05-21 2006-03-08 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4)
WO2004104575A2 (en) * 2003-05-23 2004-12-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with x-prolyl aminopeptidase 2 (xpnpep2)
DE10330842A1 (en) 2003-07-08 2005-02-10 Institut für Medizintechnologie Magdeburg GmbH, IMTM Use of the inhibitors of enzymes with activities of aminopeptidase N and / or dipeptidyl peptidase IV and pharmaceutical preparations thereof for the therapy and prevention of dermatological diseases with hyperproliferation and altered differentiation states of fibroblasts
US7678909B1 (en) 2003-08-13 2010-03-16 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
KR20060041309A (en) 2003-08-13 2006-05-11 다케다 야쿠힌 고교 가부시키가이샤 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
US7169926B1 (en) 2003-08-13 2007-01-30 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
DE10348044A1 (en) * 2003-10-15 2005-05-19 Imtm Gmbh Dual alanyl aminopeptidase and dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
DE10348023A1 (en) * 2003-10-15 2005-05-19 Imtm Gmbh New alanyl aminopeptidase inhibitors for the functional manipulation of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
DE10348022A1 (en) * 2003-10-15 2005-05-25 Imtm Gmbh New dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
US7732446B1 (en) 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
JP2008501714A (en) 2004-06-04 2008-01-24 武田薬品工業株式会社 Dipeptidyl peptidase inhibitor
WO2006019965A2 (en) 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
EP1702916A1 (en) * 2005-03-18 2006-09-20 Santhera Pharmaceuticals (Schweiz) GmbH DPP-IV inhibitors
JP4568361B2 (en) 2005-04-22 2010-10-27 アラントス・ファーマシューティカルズ・ホールディング・インコーポレーテッド Dipeptidyl peptidase-IV inhibitor
PT1942898E (en) 2005-09-14 2011-12-20 Takeda Pharmaceutical Dipeptidyl peptidase inhibitors for treating diabetes
CN101360723A (en) 2005-09-16 2009-02-04 武田药品工业株式会社 Process for preparing pyrimidinedione derivatives
DE102005054700B4 (en) 2005-11-16 2009-01-08 Imtm Gmbh New dual peptidase inhibitors as prodrugs for the treatment of inflammatory and other diseases
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
US8524654B2 (en) * 2007-05-21 2013-09-03 The Uab Research Foundation Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation
DE102007039429A1 (en) * 2007-08-21 2009-02-26 Imtm Gmbh Method for activating regulatory T cells
EP2292589A1 (en) 2009-09-02 2011-03-09 IMTM GmbH Novel multifunctional peptidase inhibitors, especially for medical use
CA2782157A1 (en) 2009-11-30 2011-06-03 Leif Einar Stern Lubricious aqueous composition
EP2366394A1 (en) 2010-03-17 2011-09-21 IMTM GmbH Characterization and validation of inhibitors and ligands of dipeptidyl aminopeptidase IV (DP IV)
EP2418196A1 (en) * 2010-07-29 2012-02-15 IMTM GmbH Dual alanyl-aminopeptidase and dipeptidyl-peptidase IV inhibitors
GR1008310B (en) * 2013-10-03 2014-10-02 Εκεφε Δημοκριτος, Phoshinic pseudopeptide derivatives for potent inhibition of aminopeptidases of the oxytocinase subfamily of m1 aminopeptidases
MX386778B (en) 2015-03-09 2025-03-19 Intekrin Therapeutics Inc METHODS FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE AND/OR LIPODYSTROPHY.
CA3058806A1 (en) 2017-04-03 2018-10-11 Coherus Biosciences Inc. Ppar.gamma. agonist for treatment of progressive supranuclear palsy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD296075A5 (en) 1989-08-07 1991-11-21 Martin-Luther-Universitaet Halle-Wittenberg,De PROCESS FOR THE PREPARATION OF NEW INHIBITORS OF DIPEPTIDYL PEPTIDASE IV
US5902790A (en) 1995-10-03 1999-05-11 Cytran, Inc. Pharmaceutical angiostatic dipeptide compositions and method of use thereof
US6429212B1 (en) 1996-08-16 2002-08-06 Ishihara Sangyo Kaisha Ltd. Medicinal composition
JPH10218789A (en) 1996-12-06 1998-08-18 Nippon Kayaku Co Ltd Activator for aids vaccine containing ubenimex as active ingredient
WO1998044923A1 (en) * 1997-04-10 1998-10-15 Sloan-Kettering Institute For Cancer Research Anti-neoplastic effects of actinonin
EP1062222A1 (en) * 1998-03-09 2000-12-27 Fondatech Benelux N.V. Serine peptidase modulators
DE19826972A1 (en) * 1998-06-18 1999-12-23 Univ Magdeburg Tech Inhibiting keratinocyte activation and proliferation, for treatment of dermatological disorders such as psoriasis or actinic precancerous states
WO2000010549A1 (en) 1998-08-21 2000-03-02 Point Therapeutics, Inc. Regulation of substrate activity
DE10025464A1 (en) * 2000-05-23 2001-12-06 Inst Medizintechnologie Magdeb Combined use of enzyme inhibitors for the therapy of autoimmune diseases, in transplants and tumor diseases, as well as combinations of pharmaceutical preparations comprising enzyme inhibitors
WO2002053170A2 (en) * 2001-01-02 2002-07-11 Institut Für Medizintechnologie Magdeburg Gmbh (Imtm) Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prophylaxis of arteriosclerosis, for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological diseases associated with fo

Similar Documents

Publication Publication Date Title
AU2002233288A1 (en) Combined use of Enzyme Inhibitors and Pharmaceutical Preparations thereof for the Treatment and Prophylaxis of Arteriosclerosis, for the Treatment and Prevention of Allergic Reactions of Type I According to the Gell and Coombs Classification, and for the Treatment and Prevention of Dermatological Diseases Associated with FO
AU2003265225A1 (en) Preparations for topical skin use and treatment
AU2003272536A1 (en) Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin
AU2003210321A1 (en) Use of sugar esters in cosmetic and/or pharmaceutical preparations
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
WO2001095899A3 (en) Pharmaceutical compositions comprising cannabidiol derivatives
AR002974A1 (en) Use of at least one cgrp antagonist for the preparation of a cosmetic, pharmaceutical and / or dermatological composition to treat red skin spots of neurogenic origin, composition obtained and cosmetic treatment procedure using said antagonist.
AU2003231878A1 (en) Pharmaceutical preparation of botulinum neurotoxin, methods of synthesis and methods of clinical use
AU2001286562A1 (en) Use of agaricus blazei murill to prevent or treat skin and other disorders
AU2002248319A1 (en) Pharmaceutical composition for the prevention and treatment of scar tissue
AU2003209150A1 (en) Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases
WO2003018535A3 (en) Novel aminobenzoephenones
AU2002325169A1 (en) Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
WO2002098386A3 (en) Use of sodium polystyrene sulfonate for tightening skin
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
WO2002070537A3 (en) Fusidic acid derivatives
HUP0204180A2 (en) External composition and its use for treating of allergic skin diseases
ATE404519T1 (en) HYPERFORINE DERIVATIVES, THEIR USE AND PREPARATIONS CONTAINING THEM
CA2387600A1 (en) Novel fusidic acid derivatives
AU2003227361A1 (en) DECOY FOR TREATING AND/OR PREVENTING Th2 CYTOKINE-ASSOCIATED ALLERGIC DISEASE, GATA3 MUTANT PROTEIN AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
AU2002241416A1 (en) Dermatological agent for the treatment of skin trauma, especially in burn conditions
AU2003258550A1 (en) Splicing-variant of the human p53 protein and use thereof in the production of pharmaceutical preparations for treating tumoural diseases
AU2002325261A1 (en) Preparation used for the topical treatment of pains and skin diseases
AU2002234617A1 (en) Cosmetic or pharmaceutical preparations of the treatment of epithelial outer tissue
AU2002240395A1 (en) Pharmaceutical preparation for the treatment of topical wounds and ulcers